Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is OPKO Health Stock a Buy?

TheMotleyFool

0 0

The coronavirus has brought many small healthcare companies into the limelight in 2020 -- from small drugmakers testing experimental therapies to quiet diagnostics businesses suddenly facing demand for hundreds of millions of tests.

OPKO Health (NASDAQ: OPK) has found itself in investors' spotlight this year, having parlayed its 2015 acquisition of BioReference Labs into a leading position managing coronavirus testing for sports leagues. But interested investors should consider two key questions: What is OPKO beyond its testing programs, and could the company offer good returns in the future?

Image source: Getty Images

Source Fool.com

Like: 0

OPK

Share